Case Study
With access to our team of experts, our sponsors have achieved significant results over the years. Here you can view some of our recent success stories.
Breast Cancer:
Target Therapy
OPIS was able to speed up the clinical study activities by improving the enrollment rate
Multiple Myeloma Global Trial
OPIS pan-European coverage allows the simultaneous activation of 51 sites in 12 countries according to pre-scheduled timelines
Multiple Sclerosis
OPIS was in charge of 35 studies distributed all over Europe. More than 250 sites have been activated
Post-Cataract Surgery Infection
Excellent performance: more than 863 patients screened and 808 patients randomized in less than 3 months
Heart Failure
Global management capabilities allowed us to activate 495 different sites in 25 countries maintaining a full track of all KPIs
AML & Multiple Myeloma
OPIS takes part in Phase I/IIa studies set up to show the safety and efficacy of CAR- T cells in acute myeloid leukemia and multiple myeloma
Covid-19 studies
OPIS is managing 2 international phase II/III studies for the treatment of SARS-CoV-2
Allergic Rhinoconjunctivitis
OPIS was able to enroll more than 146 childrens in 17 activated sites
